RxRights to Congress: Please Use Common Sense When It Comes to Personal Drug Importation

WASHINGTON--(BUSINESS WIRE)-- Editor’s Note: Lee Graczyk was quoted on a related topic in a recent article on CNBC.com. Click here for the full story. Graczyk is available for media interviews.

Lee Graczyk, lead organizer of RxRights, issued the following on behalf of U.S. seniors fighting the high cost of pharmaceuticals through drug importation:

“Congress needs to exercise common sense and recognize that personal drug importation from legitimate, licensed pharmacies is a necessity for millions of Americans today.

“From the pending PROTECT IP Act to the Department of Justice’s recent announcement of Google’s pharmacy ad settlement, what’s getting lost in all this legal mumbo jumbo is a common sense approach.

“Drug importation — in this case we’re talking about buying affordable prescription medication from legitimate online pharmacies — has been in practice since the 1990s.

“Even the U.S. Food and Drug Administration, in its own guidelines on import operations, permits shipments of products that appear to violate FDA statutes to enter the country. More specifically, ‘when quantity and purpose are clearly for personal use, and the product does not present an unreasonable risk to the user.’

“This is the classic glovebox versus mailbox debate. It defies common sense that consumers can drive across the border to Canada to purchase prescription medications and store them in their glove boxes, yet those same consumers — and others — may not be able to have the same brand-name medications delivered to their mailboxes.

“Now that Congress is back in session, I am urging all Americans to contact their representatives to encourage them to use common sense when it comes to the need for drug importation from safe, legitimate online pharmacies.”

About RxRights

RxRights is a national coalition of individuals and organizations concerned with the high cost of prescription drugs in the U.S. For more information, visit www.RxRights.org.


Lee Graczyk, 1-866-703-5442
[email protected]

KEYWORDS:   United States  North America  Canada  District of Columbia

INDUSTRY KEYWORDS:   Online Retail  Health  Public Policy/Government  Healthcare Reform  Congressional News/Views  Pharmaceutical  Public Policy  White House/Federal Government  Retail  FDA  General Health